The whole cannabinoid family

Cannabinoid FAQ — the family, not one molecule

Most questions about CBG are really questions about the family it heads: where the acids come from, why the varins matter, which molecules get you high, what the law and the drug test care about, and how much of the research was done in people.

How to read this. Chemical identity, biosynthesis, lab behaviour and whether a compound is intoxicating are stated as fact, each with an evidence grade. Effect and benefit claims are reported as the claim of others ("marketed as…," "proponents say…," "a preliminary study reported…"), together with their limits. Grade ladder (six rungs): [Established] › [Demonstrated] › [Emerging] › [Low] › [Hypothesized] › [Not-supported]. Not-supported means a question was tested and the evidence weighs against the claim; an untested question never gets it. A question with no primary study in our registry is marked as No primary evidence / catalogue in progress, a coverage state that sits off the ladder. Grade chips link to /evidence. Nothing here is medical or legal advice.

The mother cannabinoid & CBG basics

What is the "mother cannabinoid"?

The "mother cannabinoid" is CBG (cannabigerol), and the nickname really belongs to its acid form, CBGA, which the cannabis plant converts into the acid forms of THC, CBD and CBC. Follow any major cannabinoid back far enough and you arrive at that single parent molecule.

What is CBG, and why is it called the mother cannabinoid?

CBG (cannabigerol) is a non-intoxicating cannabinoid found in hemp and cannabis, called the "mother" because its acid form, CBGA, is the first one the plant makes. From there the plant turns CBGA into the building blocks of THC, CBD and CBC. On the chemistry the record is solid; what CBG does in people is a younger question, with human evidence at an early stage.

Where does CBG come from in the plant?

CBG comes from cannabigerolic acid (CBGA), which cannabis and hemp assemble from simpler precursors. Enzymes convert most of that CBGA into the acids behind THC, CBD and CBC, and gentle heat turns what is left into neutral CBG, so fresh plants hold only small amounts of it.

What is CBGA?

CBGA (cannabigerolic acid) is the first cannabinoid the plant builds and the acidic parent of the rest, the precursor it converts into THCA, CBDA and CBCA. Raw, unheated hemp contains it, and in that form it is non-intoxicating. Heat strips its acid group off as CO₂ and leaves CBG behind.

Is CBG psychoactive?

CBG is non-intoxicating: it produces none of the "high" or impairment that THC causes. In laboratory studies it blocks the CB₁ receptor as a competitive antagonist rather than switching it on (Cascio 2010). "Psychoactive" is the wider word, covering anything that touches mood, and one small trial reported reduced anxiety, which is why "non-intoxicating" is the precise description.

The cannabinoid family — classes & vocabulary

How many cannabinoids does the cannabis plant make?

Cannabis makes a large family of cannabinoids, commonly cited as more than a hundred identified compounds, but only a handful, such as THC, CBD and CBG, reach meaningful amounts. The rest turn up in traces, and few have been studied in people. The count keeps climbing as analytical methods improve.

What are minor cannabinoids?

Minor cannabinoids are the ones cannabis and hemp produce in small amounts, such as CBG, CBN, CBC, THCV and CBDV, as distinct from the two majors, THC and CBD. "Minor" refers to abundance, and importance is a separate matter. Where they fall short is human research: most have far less of it behind them.

Are minor cannabinoids proven to work?

In humans, mostly not. Minor cannabinoids are marketed for sleep, calm, focus and more, yet for most of them controlled human evidence is limited or absent, and much of what circulates is marketing or an extrapolation from lab and animal work. CBG Atlas reports those promises as claims and grades the evidence behind each one. (Not medical advice.)

What are cannabinoid acids?

Cannabinoid acids are the forms the living plant actually makes: CBGA, THCA, CBDA and CBCA, each carrying a carboxylic-acid group. Raw, they are non-intoxicating, THCA included. Heat removes the acid group and converts them into the familiar neutral cannabinoids CBG, THC, CBD and CBC.

What are varin cannabinoids?

A varin is a cannabinoid built on a shorter, three-carbon (propyl) side chain in place of the usual five-carbon (pentyl) one. The best known are THCV, CBDV and CBGV, the counterparts of THC, CBD and CBG. The plant makes them from a separate precursor acid, CBGVA, and usually in small amounts.

What's the difference between phytocannabinoids, endocannabinoids, and synthetic cannabinoids?

The difference is where they come from. Phytocannabinoids such as CBG, THC and CBD are made by the cannabis plant. Endocannabinoids such as anandamide are signalling molecules the human body makes, acting on the same receptor system. Synthetic cannabinoids are lab-made compounds designed to hit those receptors, and some of them can be far more potent and riskier.

Chemistry & biosynthesis

How are cannabinoids made in the plant (biosynthesis)?

The plant joins two building blocks into cannabigerolic acid (CBGA), the parent cannabinoid, and dedicated enzymes called synthases then convert CBGA into THCA, CBDA and CBCA. Those acids become THC, CBD and CBC only once they are heated, or decarboxylated. CBG is simply CBGA's own neutral form.

What is decarboxylation?

Decarboxylation is the heat-driven reaction that turns a raw cannabinoid acid into its neutral form by removing a carboxyl group as carbon dioxide. It happens whenever cannabis is dried, aged, cooked or vaporized, and it is how CBGA becomes CBG and THCA becomes THC: heat, in short, is what activates cannabinoids.

What's the difference between a cannabinoid acid and its neutral form?

Heat is the difference. The raw plant makes the acid form (CBGA, THCA), and heating removes the acid group to leave the neutral form (CBG, THC). The two are chemically distinct molecules, and the change can matter a great deal: raw THCA is non-intoxicating, heated THC is intoxicating.

Are cannabinoids water-soluble?

No: CBG, CBD, THC and the other cannabinoids are lipophilic ("fat-loving") and essentially insoluble in water. Hence the oils and carriers on the shelf; anything sold as "water-soluble" relies on emulsions or nanoparticles to disperse the cannabinoid. Fat solubility also shapes how the body absorbs and stores them.

What's the difference between cannabinoids and terpenes?

Cannabinoids and terpenes are separate chemical classes. Cannabinoids such as CBG, THC and CBD act on the body's cannabinoid receptor system; terpenes are the aromatic compounds that give cannabis, and many other plants, their smell and flavour. Hemp contains both. Some propose that the two act together, the unproven "entourage effect."

Intoxication, receptors & the body

Do cannabinoids get you high?

Only some do, chiefly THC, which causes the cannabis "high" by activating the CB₁ receptor. Most of the others, including CBG, CBD, CBC, CBN and acids such as CBGA and THCA, are non-intoxicating. The word "cannabinoid" on a label, by itself, tells you little about whether a product intoxicates.

Which cannabinoids are non-intoxicating?

Most of them: CBG, CBD, CBC, CBDV, CBGV and the raw acids (CBGA, THCA, CBDA) are all considered non-intoxicating. CBN is generally non-intoxicating, or at most weakly so, and THCV depends on dose: at low doses it is non-intoxicating. THC, the cannabinoid behind the "high," is the clear exception.

Which cannabinoids are intoxicating?

The main one is delta-9 THC, which produces the "high" through the CB₁ receptor. Other THC forms, such as delta-8, delta-10, THC-O and further analogs, are reported to intoxicate as well, and THCV can move toward intoxication as the dose rises. CBG, CBD and most other cannabinoids are non-intoxicating.

Do all cannabinoids work through CB1 and CB2 receptors?

No: CB₁ and CB₂ are central, but cannabinoids also act at targets largely outside the classic CB receptors. In laboratory studies CBG engages α₂-adrenoceptors and blocks 5-HT₁ₐ serotonin receptors (Cascio 2010), and it modulates TRP channels (De Petrocellis 2011). Reason about a cannabinoid from CB₁ and CB₂ alone and you are reading an incomplete map.

What is the endocannabinoid system?

The endocannabinoid system (ECS) is the body's own cannabinoid signalling network, made up of receptors (CB₁, CB₂), the "endocannabinoid" molecules that activate them, and the enzymes that build and break down those molecules. It helps regulate processes such as mood, appetite and pain signalling, and plant cannabinoids act on it from outside.

What is the entourage effect, and is it proven?

The entourage effect remains an unproven hypothesis: the idea that cannabinoids and terpenes work better together than apart. Plausible and widely cited, it rests on limited controlled human evidence with mixed results, and proponents often overstate it. For now, "interesting hypothesis" is as far as the evidence takes it.

How CBG compares

How is CBG different from CBD?

CBG and CBD are different molecules that act on different laboratory targets, though both are non-intoxicating. In vitro, CBG acts on α₂-adrenoceptors and blocks 5-HT₁ₐ serotonin receptors (Cascio 2010), while CBD activates 5-HT₁ₐ, pushing it the other way. The wider gap is in the research: CBD has an FDA-approved epilepsy medicine and far more study, while CBG's human evidence in our registry is one small trial.

How is CBG different from THC?

The core difference is intoxication: THC produces a "high" and CBG does not. THC works as a partial agonist at the CB₁ receptor, and that activation causes the high and the impairment. In the lab CBG does the opposite at the same receptor, acting as a CB₁ competitive antagonist (Cascio 2010), and the one controlled human trial in our registry found no intoxication. Their chemistry and legal status differ too.

What's the difference between CBG and CBN?

CBG and CBN sit at opposite ends of the plant's chemistry. CBG is the neutral form of CBGA, where biosynthesis begins, and it is non-intoxicating. CBN forms late, as THC oxidizes and breaks down while cannabis ages. CBN is the one heavily marketed for sleep, a use controlled human studies have not established, and CBG is not a sleep product.

Legality & plant type

What's the difference between hemp and marijuana?

The difference is legal; botanically they are the same plant. Hemp and marijuana are one species, Cannabis sativa, and US law separates them by THC content: at or below 0.3% delta-9 THC by dry weight the plant is "hemp," and above that it is "marijuana." One plant, two legal labels, and a THC number decides which applies.

Are any cannabinoids FDA-approved as medicines?

A few are: the FDA has approved cannabidiol (Epidiolex) for certain rare seizure disorders, along with THC-based drugs (dronabinol, nabilone) for specific uses. No minor cannabinoid has joined them: CBG, CBN and THCV are not FDA-approved to treat any condition. Selling legally as hemp and winning approval as a medicine are separate tracks.

Products, testing & buying

What do "full-spectrum," "broad-spectrum," and "isolate" mean?

They describe how much of the plant a hemp extract keeps. Full-spectrum retains the plant's full range of cannabinoids, trace THC included (up to 0.3%). Broad-spectrum keeps multiple cannabinoids with the THC removed. Isolate is one purified cannabinoid and nothing else. The choice affects drug-test risk and any claimed "entourage" interaction.

What is a Certificate of Analysis (COA)?

A Certificate of Analysis (COA) is a lab report from an independent third party on one specific product batch. A good one shows that the cannabinoid content matches the label, confirms THC sits inside legal limits, and screens for contaminants: pesticides, solvents, heavy metals and microbials. A missing COA, or one that fails to match the product, is a red flag.

Which cannabinoids can make you fail a drug test?

Mainly THC: standard tests look for THC and its metabolite, so THC itself, and full-spectrum products carrying trace THC, pose the real risk. CBN can also cross-react with THC immunoassays. The tests target neither CBG nor CBD, yet a CBG or CBD product can still carry enough THC to trigger a positive.

Safety & interactions

Is CBG safe?

CBG's safety has not been fully established: the only controlled human data in our registry come from a single acute trial, which reported no impairment. Long-term use, higher or repeated doses, and drug interactions have not been studied in any depth. Because laboratory studies show CBG acts on α₂-adrenoceptors that help regulate blood pressure (Cascio 2010), consult a clinician if you take cardiovascular medication.

Can cannabinoids interact with medications?

They may: many drugs are metabolized by the liver's CYP450 enzymes, which cannabinoids can affect, so interactions are plausible, much like the familiar grapefruit-juice warning. Compound-specific human data are limited. CBG also acts on α₂-adrenoceptors linked to blood pressure (Cascio 2010), so take extra care with cardiovascular medication. Ask a doctor or pharmacist.

Research & how this atlas works

Which cannabinoids are being researched the most?

THC and CBD, by a wide margin, and CBD especially: it has an FDA-approved medicine and many trials behind it. The minor cannabinoids (CBG, CBN, CBC, THCV and the acids) have far less human research, often a handful of studies and mostly preclinical. Thin is the accurate word for that record, and inflating it would mislead the people reading the label.

Why does CBG Atlas grade its claims?

Because a claim is only as strong as the evidence behind it, and a buyer deserves to see that strength before trusting a label. Every substantive claim carries a grade, from [Established] down to [Not-supported], which puts verified chemistry and hopeful marketing on one scale where the difference shows at a glance. Where evidence is thin or absent, the answer reads "catalogue in progress" in place of a guess dressed up as a finding.

What does "[Not-supported]" mean on this site?

On this site, [Not-supported] is the strongest negative grade, and it means the question was actually tested and the evidence came out against the claim. We use it sparingly, and only once someone has run the experiment. A question studied in neither direction, such as the popular idea that CBG lowers eye pressure (intraocular pressure) for glaucoma, is labelled [No primary evidence] / catalogue in progress, never [Not-supported]. One label records an absence, the other a finding, and they never overlap.

Sources

  • Cascio 2010 — PMID 20002104 — in vitro, CBG is an α₂-adrenoceptor agonist, a 5-HT₁ₐ (serotonin) receptor antagonist and a competitive CB₁ receptor antagonist. Grade: Demonstrated · in vitro. (The basis for the α₂ blood-pressure caution and for the CB₁ antagonism claim.)
  • De Petrocellis 2011 — PMID 21175579 — CBG modulates TRP channels in vitro; the study characterized several cannabinoids, including CBN as a potent TRPA1 agonist and desensitiser. Grade: Demonstrated · in vitro.
  • Borrelli 2013 — PMID 23415610 — in a mouse (murine) model of colitis, CBG reduced inflammation; this is animal evidence, not human. Grade: Demonstrated · in vivo (animal).
  • Appendino 2008 — PMID 18681481 — in vitro, several major cannabinoids showed antibacterial activity, MRSA included. Grade: Demonstrated · in vitro.

Where an answer mentions a possible effect, it reports what others have claimed and grades the evidence for it. These are not our claims, and they are not advice. Nothing here diagnoses, treats, cures or prevents any disease. Legal status changes from place to place, and each statement about it is dated. Peregrine Biopharma funds the platform and holds no editorial authority.